Acute Limb Ischemia, Atheroembolization, and Compartment Syndrome

43.1Recognising acute limb ischaemia and starting heparin first

Acute limb ischemia is managed as a vascular emergency because the first decision is not “which operation?” but “is this limb threatened, and how fast must flow be restored?” The initial bedside assessment should define limb viability using sensory findings, motor function, and hand-held Doppler signals rather than relying on appearance alone. Once acute limb ischemia is confirmed or strongly suspected, therapeutic unfractionated heparin is started immediately unless there is a contraindication, because the early priority is to prevent thrombus propagation while the limb is being classified and the revascularization pathway is organized. PAD 2024 · Editor's Choice European 2020

The examination must be repeated, not merely documented once. Rutherford class can change while the patient is in the emergency department, imaging suite, or operating room queue; worsening sensory loss, new weakness, or loss of venous Doppler signal should trigger escalation. Rutherford · 1997 Arterial Doppler silence alone does not define an irreversible limb, but profound anesthesia, paralysis with rigor, and absent arterial and venous Doppler signals define a different clinical problem: a limb in which attempted reperfusion may be futile or dangerous.

Heparin should not delay definitive action. In a threatened limb, anticoagulation, analgesia, vascular consultation, imaging, and preparation for intervention are parallel steps. The guideline-based pathway is consistent: anticoagulate when safe, assess viability rapidly, obtain urgent imaging when revascularization is needed and the limb can tolerate it, and select the revascularization method according to Rutherford category, anatomy, patient risk, and local expertise. ACC/AHA 2024 · Editor's Choice European 2020

Atheroembolisation belongs in the same early differential because it can mimic occlusive acute limb ischemia while following a different therapeutic logic. The classic “blue-toe” problem is not simply a small version of large-vessel thrombosis; it is an embolic or cholesterol-crystal phenomenon requiring careful evaluation of source, distribution, and management boundaries. Review approach diagnosis 2025 · Cholesterol Embolization Syndrome 2010 The practical teaching point for trainees is to decide whether the patient has a globally threatened limb requiring urgent revascularization, or a distal embolic syndrome in which indiscriminate thrombolysis or operation may not address the underlying process.

43.2Rutherford classification: bedside categories that drive modality choice

Rutherford classification is the common language that turns a frightening presentation into a sequence of decisions. Rutherford · 1997 Class I is viable: there is no immediate limb threat, no sensory loss, no muscle weakness, and arterial Doppler signals are audible. This patient still needs diagnosis and treatment, but there is usually time to image deliberately and plan the least hazardous revascularization strategy.

Class IIa is marginally threatened: the limb is salvageable with prompt treatment, sensory loss is minimal and confined to the toes, there is no muscle weakness, arterial Doppler is often inaudible, and venous Doppler remains audible. This is the category in which catheter-directed thrombolysis or other endovascular approaches may be attractive when anatomy, bleeding risk, and institutional capability align, because the limb is threatened but not yet demanding instant flow restoration at any cost. Editor's Choice European 2020 · Catheter Directed Thrombolysis 2022 · Rutherford · 1997

Class IIb is immediately threatened: the limb is salvageable only with immediate revascularization. Sensory loss extends beyond the toes, rest pain is present, and there is mild to moderate weakness; arterial Doppler is inaudible while venous Doppler remains audible. For trainees, weakness is the critical inflection point: once motor deficit appears, the pathway must compress toward the fastest reliable method of restoring inflow and outflow, whether that is open embolectomy, bypass, percutaneous mechanical thrombectomy, thrombolysis-assisted therapy, or a hybrid approach. Editor's Choice European 2020 · Rutherford · 1997

Class III is irreversibly damaged: major tissue loss and permanent nerve injury are expected, with profound anesthesia, paralysis with rigor, and absent arterial and venous Doppler signals. In this setting, primary amputation is the recommended pathway rather than heroic revascularization. The point is not nihilism; it is recognition that reperfusing dead muscle may expose the patient to systemic harm without restoring a functional limb. Editor's Choice European 2020 · Rutherford · 1997

The classification is dynamic and must be reconciled with the mechanism. Non-embolic thrombosis, embolic occlusion, graft thrombosis, in situ atherosclerotic disease, and atheroembolisation can present differently and may require different procedures even within the same Rutherford class. Modern practice includes catheter-directed lysis, aspiration thrombectomy, rotational/mechanical thrombectomy, open embolectomy, bypass, and hybrid combinations, but the central rule remains simple: the more threatened the limb, the less tolerance there is for slow therapy. Editor's Choice European 2020 · Safety efficacy mechanical 2023 · ALI 2020

43.3STILE and TOPAS — what randomised evidence says about thrombolysis vs surgery

The randomized evidence should be taught as a framework rather than as a frozen recipe. STILE randomized 393 patients with non-embolic acute or subacute lower-extremity ischemia to catheter-directed thrombolysis or surgical revascularization. STILE · 1994 Surgery had better 30-day outcomes overall, but in patients with symptoms for less than 14 days, thrombolysis was associated with better amputation-free survival and shorter hospital stay; in more chronic presentations beyond 14 days, surgery was favoured.

The practical lesson from STILE is that duration and biology matter. STILE · 1994 Fresh thrombus behaves differently from organized occlusion, and a trial result in non-embolic disease should not be uncritically applied to embolic acute limb ischemia. STILE also showed that thrombolysis reduced or avoided planned surgical procedures in more than half of patients, which remains relevant when lysis can reveal the underlying lesion and convert an uncertain operation into a more targeted repair.

TOPAS randomized adults with acute leg arterial occlusion to recombinant urokinase or surgery as the initial treatment. Amputation-free survival was similar between urokinase and surgery, at 71.8% and 74.8% respectively. Thrombolysis reduced the number of surgical procedures, but the trade-off was more bleeding, including intracranial hemorrhage in 1.6% of patients receiving thrombolysis compared with none in the surgical group. TOPAS · 1998

The bedside translation is that thrombolysis is not “less invasive” in the sense of being lower risk for every patient. It is a temporising, information-generating, and clot-clearing strategy whose success depends on time, bleeding risk, monitoring capacity, and limb viability. A patient with Rutherford IIa ischemia and acceptable bleeding risk may be a good lysis candidate; a patient with Rutherford IIb ischemia and motor deficit generally needs a method that restores flow immediately. Editor's Choice European 2020 · Catheter Directed Thrombolysis 2022 · TOPAS · 1998

Systematic review evidence reinforces the same caution. Across older comparisons of initial surgery and thrombolysis, there was no clear 30-day difference in limb salvage, amputation, or death, while thrombolysis carried increased signals for major hemorrhage and distal embolisation. Endo Vs Surgical 2019 · Surgery versus thrombolysis 2018 Contemporary endovascular practice has evolved beyond STILE and TOPAS protocols, but the enduring decision remains anatomy-, Rutherford-, bleeding-risk-, and expertise-dependent. Endovascular Versus Surgical 2020

43.4After revascularisation: compartment syndrome, anticoagulation, and reperfusion injury

Revascularization is not the end of acute limb ischemia care; it is the start of the reperfusion phase. The surgeon must anticipate swelling, pain, metabolic stress, and recurrent thrombosis, especially after delayed presentation or prolonged ischemia. Current guideline pathways explicitly include consideration of four-compartment fasciotomy after high-risk revascularization, particularly when presentation is delayed, ischemia has been prolonged, or reperfusion swelling is significant. PAD 2024 · ACC/AHA 2024

Compartment syndrome after revascularization is a clinical diagnosis supported by pressure measurement when the examination is equivocal or the patient cannot be assessed reliably. Whitesides introduced the simple needle-manometer method for tissue-pressure measurement, and modern devices follow the same principle of quantifying pressure when clinical uncertainty is dangerous. Whitesides 1975 Measurement should assist judgment, not replace it, because post-ischemic muscle can deteriorate quickly after flow is restored.

The most useful quantitative concept is the differential pressure: diastolic blood pressure minus compartment pressure. McQueen and Court-Brown found that a delta pressure below 30 mmHg identified patients requiring decompression without missed compartment-syndrome cases in their tibial-fracture cohort, while absolute pressure thresholds would have produced many unnecessary fasciotomies. McQueen compartment pressure 1996 The threshold is widely applied as a decision aid, but trainees should remember that it was derived outside the ALI reperfusion setting and must be interpreted alongside serial examination. McQueen compartment pressure 1996

Fasciotomy timing is a failure-sensitive part of ALI care. Fasciotomy ALI · 2022 Delayed decompression after evolving compartment syndrome risks irreversible neuromuscular injury, while unnecessary fasciotomy exposes the patient to wound morbidity and prolonged recovery. Delayed Fasciotomy Is 2019 The operative decision should be made early in patients with high-risk reperfusion, especially when the limb has had prolonged ischemia or the clinical examination is becoming unreliable. Necessity Role Outcomes 2023

Anticoagulation after revascularization is not a rote continuation of the emergency heparin order. The immediate goal is to prevent recurrent thrombosis while bleeding, fasciotomy wounds, thrombolysis exposure, and the underlying cause of occlusion are reassessed. The broader guideline pathway connects acute management to secondary-prevention antithrombotic therapy, but the exact transition must be individualised to mechanism, bleeding risk, renal and contrast considerations, and the procedure performed. PAD 2024 · Editor's Choice European 2020

43.5ESVS 2020 and AHA/ACC/SVS 2024 — where the acute limb-ischaemia pathway converges

The contemporary pathway is remarkably consistent across major guidelines. Both the ESVS acute limb-ischemia guideline and the 2024 multisociety PAD guideline organise care around immediate anticoagulation when not contraindicated, rapid limb-viability assessment, urgent imaging when revascularization is required, and modality choice according to Rutherford category. PAD 2024 · Editor's Choice European 2020 This convergence is useful for trainees because it reduces ALI management to a repeatable emergency sequence rather than a menu of disconnected techniques.

The shared pathway also clarifies what not to do. Do not send a Rutherford IIb limb through a slow diagnostic pathway while weakness progresses. Rutherford · 1997 Do not attempt revascularization of a Rutherford III limb as though it were merely late IIb ischemia. Do not choose thrombolysis because it is familiar if the patient’s limb cannot tolerate the time required or the patient cannot tolerate the bleeding risk. Editor's Choice European 2020 · TOPAS · 1998

Modern registry and population data add context that trials cannot provide. Contemporary vascular practice includes open and endovascular ALI care across diverse centers, with real-world amputation and mortality outcomes influenced by case mix, center capability, and reporting structure. ALI 2024 · VQI ALI schermerhorn 2017 National inpatient and registry analyses are therefore useful benchmarks, but they should not replace bedside Rutherford classification or anatomy-specific procedural planning. ALI 2025

Nonrevascularisation is sometimes appropriate, but it must be an explicit decision rather than therapeutic drift. ALI 2024 Class III limbs proceed to primary amputation; selected patients may also fall outside a revascularization pathway because the limb, the patient, or the goals of care make intervention nonbeneficial. The safe practice pattern is to document the viability assessment, the reason revascularization is or is not being pursued, and the plan for anticoagulation, amputation, palliation, or surveillance as appropriate. Editor's Choice European 2020

The final teaching point is that acute limb ischemia care fails at transitions: emergency department to imaging, imaging to intervention, intervention to recovery, and recovery to secondary prevention. A disciplined ALI pathway keeps heparin, Rutherford class, imaging, revascularization urgency, fasciotomy risk, and antithrombotic transition visible at every handoff. That structure is how guidelines become limb salvage rather than paperwork. PAD 2024 · ACC/AHA 2024 · Editor's Choice European 2020